Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

C4 Therapeutics (CCCC) Capital Expenditures (2019 - 2026)

C4 Therapeutics has reported Capital Expenditures over the past 8 years, most recently at $38000.0 for Q1 2026.

  • For Q1 2026, Capital Expenditures changed N/A year-over-year to $38000.0; the TTM value through Mar 2026 reached $645000.0, up 258.33%, while the annual FY2025 figure was $607000.0, 237.22% up from the prior year.
  • Capital Expenditures for Q1 2026 was $38000.0 at C4 Therapeutics, up from $11000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $3.1 million in Q2 2022 and troughed at -$1.8 million in Q3 2022.
  • A 5-year average of $87733.3 and a median of $38000.0 in 2026 define the central range for Capital Expenditures.
  • Biggest five-year swings in Capital Expenditures: plummeted 1000.92% in 2022 and later skyrocketed 2161.54% in 2025.
  • Year by year, Capital Expenditures stood at -$982000.0 in 2022, then crashed by 56.11% to -$1.5 million in 2023, then surged by 99.74% to -$4000.0 in 2024, then surged by 375.0% to $11000.0 in 2025, then skyrocketed by 245.45% to $38000.0 in 2026.
  • Business Quant data shows Capital Expenditures for CCCC at $38000.0 in Q1 2026, $11000.0 in Q4 2025, and $302000.0 in Q3 2025.